Range Filler Filler: FDA 510(k) Clears Abyrx,™ Absorbable Hemostatic Bone Putty

Abyrx, Inc., a privately-held therapeutic device company, has announced the US FDA Clearance of its new Absorbable Hemostatic Bone Putty (AHBP) for clinical use in the country. The company says this is new product shows it’s offering a vertically integrated product strategy.

Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Absorbable Hemostatic Bone Putty (AHBP™) (via PR Newswire)

IRVINGTON, N.Y., June 12, 2013 /PRNewswire/ — Abyrx, Inc., a privately-held therapeutic device company, today announced that the United States Food and Drug Administration has cleared its new Absorbable Hemostatic Bone Putty (AHBP) for clinical use in the United States. AHBP is provided ready-to-…

published: June 20, 2013 in: Approval/Clearance, Orthopaedics

Most read

Latest

^